Pregled bibliografske jedinice broj: 1016588
Sources, Chemistry, and Biological Potential of Ellagitannins and Ellagic Acid Derivatives
Sources, Chemistry, and Biological Potential of Ellagitannins and Ellagic Acid Derivatives // Studies in Natural Products Chemistry / Rahman, Atta-ur (ur.).
Lahti: Elsevier, 2018. str. 189-221 doi:10.1016/B978-0-444-64181-6.00006-1
CROSBI ID: 1016588 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Sources, Chemistry, and Biological Potential of
Ellagitannins and Ellagic Acid Derivatives
Autori
Lorenzo, Jose M. ; Munekata, Paulo E. ; Putnik, Predrag ; Bursać Kovačević, Danijela ; Muchenje, Voster ; Barba, Francisco J.
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, znanstveni
Knjiga
Studies in Natural Products Chemistry
Urednik/ci
Rahman, Atta-ur
Izdavač
Elsevier
Grad
Lahti
Godina
2018
Raspon stranica
189-221
ISBN
978-0-444-63603-4
Ključne riječi
Polyphenols ; Bioactive substances ; Chemical composition
Sažetak
The consumption of polyphenols is considered an important part of a healthy life style and is related to reducing the risk for diseases. Ellagitanins (e.g., vescalagin, punicalagin, and castalagin) and ellagic acid and its derived compounds (e.g., urolithin) have been receiving attention in recent years as bioactive substances. This class of phenolic substances can be found in berries, pomegranates, walnuts, almonds, and other plant material that is consumed as traditional medicine to treat inflammatory diseases. Human gut microbiota are considered to play an important role in the bioactivity of ellagic acid derivative activity due to the production of urolithin and its antiinflammatory potential. Many studies have been clarifying, at least in part, the mechanism involved in the bioactivity of ellagitannins and ellagic acid and its derivatives in a number of areas: attenuation of the deleterious effect of oxidized low-density lipoprotein-induced endothelial dysfunction by modulating miR-27 expression and the ERK/PPAR-γ pathway on cardiovascular protection ; inhibition of α- glucosidase and lipogenic gene expression in diabetes ; inhibition of MMP-9 secretion and expression in malaria ; mediation of estrogen receptor α-dependent gene expression and prevention of hepatocyte growth factor and phosphatidylinositol 3-kinase/AKT activation in cancer cells ; inhibition of β-amyloid fibrillation and protection against neurotoxicity and paralysis in Alzheimer's disease ; inhibition of lipopolysaccharide- induced inflammation macrophages by inhibiting the IκBα and p65 phosphorylation involved in NF-κB activation in inflammatory diseases.
Izvorni jezik
Engleski
Znanstvena područja
Prehrambena tehnologija
Napomena
Inozemne institucije koautora na radu:
Centro Tecnológico de la Carne de Galicia, Spain ;
University of Fort Hare, Alice, South Africa ;
Universitat de València, València, Spain
POVEZANOST RADA
Ustanove:
Prehrambeno-biotehnološki fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus